Investing in medical research and advancements not only improves treatments and cures for patients worldwide, but strengthens our country’s healthcare industry. As Ohio’s leading cancer research organization, OCR’s mission to cure and prevent many forms of cancer is dependent upon policymakers and major donors understanding the importance of funding medical science. The following Crain’s Cleveland Business article written by Cleveland-based BioEnterprise President and CEO Aram Nerpouni explains the value of funding such innovation.

Click the link to read the Crain’s article: